Delivery Order SPE2DB20D9127-SPE2DB22FPPB2

Award Date 7/25/22
Potential Completion Date 7/26/22
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,790.00, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4557037430 NARCAN 4 MG NASAL SPRAY 2S, a critical pharmaceutical product used to treat opioid overdoses. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, a $1,629.60 firm fixed-price delivery order, is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a medication used to treat opioid overdose. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program,...
This federal contract award, valued at $6,790.00, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medical product. The award is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which provides...
The federal contract award SPE2DB20D9127|SPE2DB24FPPA2 was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,202.72 firm fixed-price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to reverse opioid overdoses. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA,...
This federal contract award from the Defense Logistics Agency (DLA) is a delivery order issued to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,649.94 firm fixed-price award is for the delivery of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to reverse opioid overdose. This order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,518.40 firm fixed-price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose. The award is part of DMS Pharmaceutical Group's significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which...
This federal contract award, valued at $4,074.00, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical opioid overdose reversal medication. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,259.20 firm fixed-price delivery order is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical pharmaceutical product. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which enables the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $4,405.44 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdoses. This order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which...
This federal contract award is a delivery order valued at $4,074.00 issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the procurement of NARCAN 4 MG NASAL SPRAY 2S, a critical medication used to reverse opioid overdoses. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to...
  • SPE2DB20D9127
    Indefinite Delivery Contract
  • SPE2DB20D9127-SPE2DB22FPPB2
    Delivery Order

This federal contract award, valued at $3,251.52, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the purchase of NARCAN 4 MG NASAL SPRAY 2S, a critical pharmaceutical product used to treat opioid overdoses. This award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, which enables DMS Pharmaceutical Group to leverage its woman-owned small business status to secure direct federal awards across multiple product categories and medical domains. Through this contract, DMS Pharmaceutical Group continues to demonstrate its capability to provide specialized pharmaceutical products and medical supplies to the Department of Defense, serving as a crucial supplier in the federal pharmaceutical supply chain.

Generated 2/27/25, 1:28 PM